Patent · US Active

Influenza virus mutants and uses therefor

US9284533B2 · kind B2 · utility

21Cited by
3References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2012
Grant dateMar 15, 2016
Priority date—
Expiry dateJun 21, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16262
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.